These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 19370547)

  • 21. Comparison of the antinociceptive effect of morphine, methadone, buprenorphine and codeine in two substrains of Sprague-Dawley rats.
    Bulka A; Kouya PF; Böttiger Y; Svensson JO; Xu XJ; Wiesenfeld-Hallin Z
    Eur J Pharmacol; 2004 May; 492(1):27-34. PubMed ID: 15145702
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sunitinib (Sutent, SU11248), a small-molecule receptor tyrosine kinase inhibitor, blocks function of the ATP-binding cassette (ABC) transporters P-glycoprotein (ABCB1) and ABCG2.
    Shukla S; Robey RW; Bates SE; Ambudkar SV
    Drug Metab Dispos; 2009 Feb; 37(2):359-65. PubMed ID: 18971320
    [TBL] [Abstract][Full Text] [Related]  

  • 23. P-glycoprotein-mediated active efflux of the anti-HIV1 nucleoside abacavir limits cellular accumulation and brain distribution.
    Shaik N; Giri N; Pan G; Elmquist WF
    Drug Metab Dispos; 2007 Nov; 35(11):2076-85. PubMed ID: 17709369
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Opioid analgesics and P-glycoprotein efflux transporters: a potential systems-level contribution to analgesic tolerance.
    Mercer SL; Coop A
    Curr Top Med Chem; 2011; 11(9):1157-64. PubMed ID: 21050174
    [TBL] [Abstract][Full Text] [Related]  

  • 25. What kinds of substrates show P-glycoprotein-dependent intestinal absorption? Comparison of verapamil with vinblastine.
    Ogihara T; Kamiya M; Ozawa M; Fujita T; Yamamoto A; Yamashita S; Ohnishi S; Isomura Y
    Drug Metab Pharmacokinet; 2006 Jun; 21(3):238-44. PubMed ID: 16858128
    [TBL] [Abstract][Full Text] [Related]  

  • 26. P-gp is involved in the intestinal absorption and biliary excretion of afatinib in vitro and in rats.
    Zhang Y; Wang C; Liu Z; Meng Q; Huo X; Liu Q; Sun P; Yang X; Sun H; Ma X; Liu K
    Pharmacol Rep; 2018 Apr; 70(2):243-250. PubMed ID: 29475007
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Low sensitivity of the positron emission tomography ligand [11C]diprenorphine to agonist opiates.
    Hume SP; Lingford-Hughes AR; Nataf V; Hirani E; Ahmad R; Davies AN; Nutt DJ
    J Pharmacol Exp Ther; 2007 Aug; 322(2):661-7. PubMed ID: 17488881
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development of Simplified in Vitro P-Glycoprotein Substrate Assay and in Silico Prediction Models To Evaluate Transport Potential of P-Glycoprotein.
    Ohashi R; Watanabe R; Esaki T; Taniguchi T; Torimoto-Katori N; Watanabe T; Ogasawara Y; Takahashi T; Tsukimoto M; Mizuguchi K
    Mol Pharm; 2019 May; 16(5):1851-1863. PubMed ID: 30933526
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of P-glycoprotein in the intestinal absorption of tanshinone IIA, a major active ingredient in the root of Salvia miltiorrhiza Bunge.
    Yu XY; Lin SG; Zhou ZW; Chen X; Liang J; Liu PQ; Duan W; Chowbay B; Wen JY; Li CG; Zhou SF
    Curr Drug Metab; 2007 May; 8(4):325-40. PubMed ID: 17504222
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Uptake and efflux of the peptidic delta-opioid receptor agonist.
    Dagenais C; Ducharme J; Pollack GM
    Neurosci Lett; 2001 Apr; 301(3):155-8. PubMed ID: 11257421
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Impact of P-Glycoprotein on Opioid Analgesics: What's the Real Meaning in Pain Management and Palliative Care?
    Coluzzi F; Scerpa MS; Rocco M; Fornasari D
    Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430602
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Quantitative prediction of P-glycoprotein-mediated drug-drug interactions and intestinal absorption using humanized mice.
    Miyake T; Tsutsui H; Haraya K; Tachibana T; Morimoto K; Takehara S; Ayabe M; Kobayashi K; Kazuki Y
    Br J Pharmacol; 2021 Nov; 178(21):4335-4351. PubMed ID: 34232502
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cyclosporine-inhibitable cerebral drug transport does not influence clinical methadone pharmacodynamics.
    Meissner K; Blood J; Francis AM; Yermolenka V; Kharasch ED
    Anesthesiology; 2014 Dec; 121(6):1281-91. PubMed ID: 25072223
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lapatinib (Tykerb, GW572016) reverses multidrug resistance in cancer cells by inhibiting the activity of ATP-binding cassette subfamily B member 1 and G member 2.
    Dai CL; Tiwari AK; Wu CP; Su XD; Wang SR; Liu DG; Ashby CR; Huang Y; Robey RW; Liang YJ; Chen LM; Shi CJ; Ambudkar SV; Chen ZS; Fu LW
    Cancer Res; 2008 Oct; 68(19):7905-14. PubMed ID: 18829547
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A Conformationally Gated Model of Methadone and Loperamide Transport by P-Glycoprotein.
    Gibbs ME; Wilt LA; Ledwitch KV; Roberts AG
    J Pharm Sci; 2018 Jul; 107(7):1937-1947. PubMed ID: 29499278
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of mdr1a P-glycoprotein gene disruption, gender, and substrate concentration on brain uptake of selected compounds.
    Dagenais C; Zong J; Ducharme J; Pollack GM
    Pharm Res; 2001 Jul; 18(7):957-63. PubMed ID: 11496955
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Competitive substrates for P-glycoprotein and organic anion protein transporters differentially reduce blood organ transport of fentanyl and loperamide: pharmacokinetics and pharmacodynamics in Sprague-Dawley rats.
    Elkiweri IA; Zhang YL; Christians U; Ng KY; Tissot van Patot MC; Henthorn TK
    Anesth Analg; 2009 Jan; 108(1):149-59. PubMed ID: 19095843
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacokinetics of Single Doses of Methadone and Buprenorphine in Blood and Oral Fluid in Healthy Volunteers and Correlation With Effects on Psychomotor and Cognitive Functions.
    Strand MC; Ramaekers JG; Gjerde H; Mørland J; Vindenes V
    J Clin Psychopharmacol; 2019; 39(5):489-493. PubMed ID: 31305338
    [TBL] [Abstract][Full Text] [Related]  

  • 39. No influence of ABCB1 haplotypes on methadone dosage requirement.
    Crettol S; Déglon JJ; Besson J; Croquette-Krokar M; Hämmig R; Gothuey I; Monnat M; Eap CB
    Clin Pharmacol Ther; 2008 May; 83(5):668-9; author reply 669-70. PubMed ID: 18043693
    [No Abstract]   [Full Text] [Related]  

  • 40. Differential effects of methadone and buprenorphine on the response of D2/D3 dopamine receptors in adolescent mice.
    Barwatt JW; Hofford RS; Emery MA; Bates ML; Wellman PJ; Eitan S
    Drug Alcohol Depend; 2013 Oct; 132(3):420-6. PubMed ID: 23932842
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.